risk analysis, page-13

Two things worry me at the moment:

1. There appears to be no evidence that Phase 2 CHIME trial has started (raised by frankj). I would have thought Merck would be pushing hard to get this going.

2. Where is our partner? - given the potential market size why aren't the big players throwing themselves at this given the ongoing trial etc

For me MGT credibility is on the line - if we don't get something in the next 4 weeks ( at least one of the three potentials raised in September - 3 - 6 month timeframe) them Ill be getting very worried.